![]() |
LUNG | Pulmonx Corp |
Surgical & Medical Instruments & Apparatus |
Book value per $ invested | $ 0.32 |
Leverage | 47.31% |
Market Cap | $ 268.6m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -56.1m |
Margin | -67.17% |
Pulmonx Corporation, a medical technology company, designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. The company is headquartered in Redwood City, California.